pre-IPO PHARMA

antikor PRESS RELEASE ARCHIVE

Aug 2, 2019

Antikor Biopharma and Essex Bio-Technology Forge Strategic Alliance in FDC for Cancer Treatment


Nov 13, 2017

Antikor Advances Breakthrough Fragment Drug Conjugate (FDC) Technology Demonstrating Superior Penetration and Tolerability


Apr 19, 2016

Breakthrough Achieved by Antikor Biopharma with Fragment-Drug Conjugates


Google Analytics Alternative